Five Nobel Laureates Head to Singapore in October for the AI For Science Summit
Source: PRNewswire
Singapore's research calendar just landed a marquee event. Nobel Heroes Day — the AI For Science Summit (AFSS) — will run from October 5 to 11 across Nanyang Technological University and Singapore Management University, bringing five Nobel laureates, AI pioneers, government leaders and long-term investors...

Singapore's research calendar just landed a marquee event. Nobel Heroes Day — the AI For Science Summit (AFSS) — will run from October 5 to 11 across Nanyang Technological University and Singapore Management University, bringing five Nobel laureates, AI pioneers, government leaders and long-term investors together for a week built around one question: how AI changes the way science gets done.
The summit, co-hosted by Laureates City Holdings and Symbiosis Science with academic support from the Lindau Nobel Laureate Meetings, is themed "Science • Intelligence • Capital." Confirmed laureates include economist Sir Christopher Pissarides, chemists Benjamin List and Omar Yaghi, physicist Sir Konstantin Novoselov and immunologist Fred Ramsdell. Around 500 invited participants will attend the two-day flagship forum, alongside closed-door roundtables, a gala dinner, and a week-long public exhibition of Nobel laureate portraits by photographer Peter Badge at Gardens by the Bay.
The programme's five themes — AI for Science, open research collaboration, sovereign AI, human longevity and frontier-driven economic growth — map closely onto the conversations Singapore's own research agencies have been pushing. The summit follows earlier editions in Hong Kong and Guangzhou, and organisers say Singapore was chosen for its internationally connected research ecosystem and neutral position, which they see as a natural meeting point between scientists and the capital that funds them.
The "AI for Science" framing deserves attention. This is the branch of AI where models don't chat — they propose new molecules, screen materials and speed up drug discovery, exactly the kind of frontier work Singapore's universities and research institutes have been investing in. Pairing that with patient capital is a distinctly Singaporean pitch, given the sovereign funds and family offices that anchor the local economy.
Why it matters for Singapore: Events like this are how a small city-state stays on the map as a serious research hub. A week of Nobel laureates in Singapore generates attention that money cannot easily buy, and the public exhibition at Gardens by the Bay brings the science to the street. For anyone tracking where AI-driven discovery is heading, October in Singapore is shaping up to be the place to be.


